Paediatrics
Conditions
Interventions
conventional iron
Sponsors
Cairo university childern hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: • Children of both sexes. • Children from 6 months of age to 14 year old. • Echocardiography confirmed diagnosis of acyanotic congenital heart diseases • Children having mild iron deficiency anemia (Hemoglobin level 10 g/dL to lower limit of normal) and moderate iron deficiency anemia (Hemoglobin level 8 to 10 g/dL). • Children whose parents consented to be recruited in this study.
Exclusion criteria
Exclusion criteria: • Children who received blood transfusion or who did partial exchange transfusion in the past other 3 months. • Children with chronic diseases other than congenital heart disease such as chronic hemolytic anemia and chronic kidney disease. • Children with ongoing blood loss. • Children with diseases interfering with iron absorption such as inflammatory bowel disease, celiac disease, bowel surgery. • Children with prior history of allergy to iron preparations. • Children who underwent definitive corrective surgery of the congenial heart disease. • Children with severe iron deficiency anemia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess efficacy of liposomal iron for the treatment of iron deficiency anemia among children with congenital acyanotic heart diseases. | — |
Secondary
| Measure | Time frame |
|---|---|
| • To compare the efficacy of conventional iron versus liposomal iron for the treatment of iron deficiency anemia among children with congenital acyanotic heart diseases. • To compare the adverse effects of conventional and liposomal iron between the two groups. | — |
Countries
Egypt
Contacts
Public ContactSalma Sakr
Pediatric resident Cairo University Hospital
Outcome results
None listed